---
title: Acromion Gmbh vs ProPharma Group
slug_a: acromion-gmbh
slug_b: propharmagroup
site: cro
review_signal_gate: closed
canonical_path: /compare/acromion-gmbh/propharmagroup
---

# Acromion Gmbh vs ProPharma Group

Side-by-side profile data from each company listing on this directory.

## Acromion Gmbh

- Profile: [/companies/acromion-gmbh](/companies/acromion-gmbh)

Acromion Gmbh — European full-service CRO supporting clinical development from Phase I to IV and non-interventional studies, with expertise in clinical monitoring, data management, biostatistics, medical writing, and regulatory affairs.

Services: 12. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- EU EMA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## ProPharma Group

- Profile: [/companies/propharmagroup](/companies/propharmagroup)

ProPharma Group — ProPharma Group provides pharmacovigilance, regulatory sciences, medical information, medical writing, and biostatistics services to life sciences companies. Its regulatory offering covers FDA and European work, including an AI-assisted capability for ANDA submission development.

Services: 7. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Clinical Operations
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Data not yet provided.

### Sourcing models

- Data not yet provided.